Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
Cancer is a significant medical issue, being one of the main causes of mortality around the world. The therapies for this pathology depend on the stage in which the cancer is found, but it is usually diagnosed at an advanced stage in which the treatment is chemotherapy. Platinum drugs are among the...
Main Authors: | Maria E. Reyes, Marjorie de La Fuente, Marcela Hermoso, Carmen G. Ili, Priscilla Brebi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-05-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00901/full |
Similar Items
-
The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection
by: Assunta Venuti, et al.
Published: (2017-10-01) -
Role of CC chemokine CCL6/C10 as a monocyte chemoattractant in a murine acute peritonitis
by: Andrew M. LaFleur, et al.
Published: (2004-01-01) -
CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis
by: APMP Marino, et al.
Published: (2005-03-01) -
CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions
by: Mohammad Hassan Mohammadi, et al.
Published: (2021-06-01) -
Expression of Membrane-Bound CC Chemokine Ligand 20 on Follicular T Helper Cells in T–B-Cell Conjugates
by: Adrian Y. S. Lee, et al.
Published: (2017-12-01)